In this classification, breast cancer was divided into subtypes with different biological characteristics, such as luminal A, luminal B, HER2-enriched, basal-like, normal breast-like, etc. The subtypes have different prognoses and drug resistance. This evidence concerns the gene ERBB2 and breast cancer.